Cybin Inc. (HELP) vs Rigel Pharmaceuticals, Inc. (RIGL)
Cybin Inc. and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. Cybin Inc. and Rigel Pharmaceuticals, Inc. are of similar size ($926.4M and $894.6M). Cybin Inc. has negative trailing earnings, so its P/E is not meaningful; Rigel Pharmaceuticals, Inc. trades at 2.7×. Rigel Pharmaceuticals, Inc. has the higher net margin (116.3% vs 0.00%) and the higher return on invested capital (16.5% vs −137.9%). Across the 13 metrics below, Rigel Pharmaceuticals, Inc. leads on 12 and Cybin Inc. on 1.
Valuation
Profitability
| Metric | HELP | RIGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 91.39% | 65.16% |
| Operating margin | 0.00% | 31.45% | 0.00% |
| Net margin | 0.00% | 116.30% | 0.00% |
| Free cash flow margin | 0.00% | 3.19% | 0.00% |
| Return on equity | (86.94%) | 126.90% | (57.72%) |
| Return on assets | (72.78%) | 88.46% | (49.22%) |
| Return on invested capital | (137.88%) | 16.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack